Aspaveli

pegcetacoplan · Swedish Orphan Biovitrum AB (publ)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Aspaveli, covering 2026-01-26 to 2026-07-31. Get the full timeline:

Most recent: EMA Authorised: Aspaveli (pegcetacoplan) — Swedish Orphan Biovitrum AB (publ)